Back to Search Start Over

The Effect of Magnesium Supplementation on Vascular Calcification in CKD:A Randomized Clinical Trial (MAGiCAL-CKD)

Authors :
Bressendorff, Iain
Hansen, Ditte
Schou, Morten
Kragelund, Charlotte
Svensson, My
Hashemi, Bahram
Kristensen, Tilde
Vrist, Marie Houmaa
Borg, Rikke
Tougaard, Birgitte
Borg, Kristine
Hjortkjær, Henrik Øder
Kristiansen, Cathrine Helgestad
Carlson, Nicholas
Nasiri, Mohammad
Ashraf, Haseem
Pasch, Andreas
Brandi, Lisbet
Bressendorff, Iain
Hansen, Ditte
Schou, Morten
Kragelund, Charlotte
Svensson, My
Hashemi, Bahram
Kristensen, Tilde
Vrist, Marie Houmaa
Borg, Rikke
Tougaard, Birgitte
Borg, Kristine
Hjortkjær, Henrik Øder
Kristiansen, Cathrine Helgestad
Carlson, Nicholas
Nasiri, Mohammad
Ashraf, Haseem
Pasch, Andreas
Brandi, Lisbet
Source :
Bressendorff , I , Hansen , D , Schou , M , Kragelund , C , Svensson , M , Hashemi , B , Kristensen , T , Vrist , M H , Borg , R , Tougaard , B , Borg , K , Hjortkjær , H Ø , Kristiansen , C H , Carlson , N , Nasiri , M , Ashraf , H , Pasch , A & Brandi , L 2023 , ' The Effect of Magnesium Supplementation on Vascular Calcification in CKD : A Randomized Clinical Trial (MAGiCAL-CKD) ' , Journal of the American Society of Nephrology , vol. 34 , no. 5 , pp. 886-894 .
Publication Year :
2023

Abstract

Significance StatementMagnesium prevents vascular calcification in animals with CKD. In addition, lower serum magnesium is associated with higher risk of cardiovascular events in CKD. In a randomized, double-blinded, placebo-controlled trial, the authors investigated the effects of magnesium supplementation versus placebo on vascular calcification in patients with predialysis CKD. Despite significant increases in plasma magnesium among study participants who received magnesium compared with those who received placebo, magnesium supplementation did not slow the progression of vascular calcification in study participants. In addition, the findings showed a higher incidence of serious adverse events in the group treated with magnesium. Magnesium supplementation alone was not sufficient to delay progression of vascular calcification, and other therapeutic strategies might be necessary to reduce the risk of cardiovascular disease in CKD.BackgroundElevated levels of serum magnesium are associated with lower risk of cardiovascular events in patients with CKD. Magnesium also prevents vascular calcification in animal models of CKD.MethodsTo investigate whether oral magnesium supplementation would slow the progression of vascular calcification in CKD, we conducted a randomized, double-blinded, placebo-controlled, parallel-group, clinical trial. We enrolled 148 subjects with an eGFR between 15 and 45 ml/min and randomly assigned them to receive oral magnesium hydroxide 15 mmol twice daily or matching placebo for 12 months. The primary end point was the between-groups difference in coronary artery calcification (CAC) score after 12 months adjusted for baseline CAC score, age, and diabetes mellitus.ResultsA total of 75 subjects received magnesium and 73 received placebo. Median eGFR was 25 ml/min at baseline, and median baseline CAC scores were 413 and 274 in the magnesium and placebo groups, respectively. Despite plasma magnesium increasing significantly during the trial in

Details

Database :
OAIster
Journal :
Bressendorff , I , Hansen , D , Schou , M , Kragelund , C , Svensson , M , Hashemi , B , Kristensen , T , Vrist , M H , Borg , R , Tougaard , B , Borg , K , Hjortkjær , H Ø , Kristiansen , C H , Carlson , N , Nasiri , M , Ashraf , H , Pasch , A & Brandi , L 2023 , ' The Effect of Magnesium Supplementation on Vascular Calcification in CKD : A Randomized Clinical Trial (MAGiCAL-CKD) ' , Journal of the American Society of Nephrology , vol. 34 , no. 5 , pp. 886-894 .
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1439546797
Document Type :
Electronic Resource